MDCO - The Medicines Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue6,13844,789143,161294,547
Cost of Revenue6,65543,19060,653103,986
Gross Profit-5171,59982,508190,561
Operating Expenses
Research Development129,507138,37092,10790,388
Selling General and Administrative43,616151,012188,501273,765
Non Recurring----
Others----
Total Operating Expenses179,778332,572341,261468,139
Operating Income or Loss-173,640-287,783-198,100-173,592
Income from Continuing Operations
Total Other Income/Expenses Net-112,464-416,488218,6779,063
Earnings Before Interest and Taxes-173,640-287,783-198,100-173,592
Interest Expense-49,411-48,564-44,463-37,092
Income Before Tax-286,104-704,27120,577-164,529
Income Tax Expense-50,888-96,57667-29,733
Minority Interest---518-464
Net Income From Continuing Ops-235,216-607,69520,510-134,796
Non-recurring Events
Discontinued Operations112,060-100,678-139,682-217,950
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-123,156-708,373-119,118-352,756
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-123,156-708,373-119,118-352,756